DDC Medical, NIST Ink Deal to Commercialize Mouse Cell Line Authentication | GenomeWeb

NEW YORK (GenomeWeb News) – DDC Medical has signed a licensing agreement with the National Institute of Standards and Technology to commercialize mouse cell line authentication using STR DNA technology, the firm announced today.

The DDC mouse cell line authentication test uses STR DNA analysis for mouse DNA characterization, and the loci that are selected produce "stable robust results based on a tetranucleotide repeat, similar to the types of loci examined for human cell line authentication," the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.